Holly E. Richter, PhD, MD

Professor of Obstetrics and Gynecology, Urology and Geriatrics
University of Alabama at Birmingham
Birmingham, Alabama, United States

Holly E Richter, PhD, MD is The Endowed Chair of Obstetrics and Gynecology in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). She is Professor of Obstetrics and Gynecology, Urology & Geriatrics, past Division Director and current Research Director of the Division of Urogynecology and Pelvic Reconstructive Surgery. She is the Medical and Quality Officer of the Ambulatory OB/GYN Clinics and Director of the Urogynecology Care and Genitorectal Disorders Clinics. She is Associate Director of Gynecologic Research for the Center for Women’s Reproductive Health and past President of the Society of Gynecologic Surgeons and the American Urogynecologic Society. She serves as an Editor for the International Urogynecology Journal and Section Editor for Current Geriatrics Report and past Editor of Obstetrics & Gynecology. In 2019, Dr. Richter received the Society of Gynecologic Surgeons Distinguished Surgeon Award.
She was the Principal Investigator of the NIDDK-sponsored Urinary Incontinence Treatment Network and the NICHD-sponsored Pelvic Floor Disorders Network since its inception in 2001. She oversees other NIH (R01, R03) and industry sponsored research. She was also the recipient of a 10 year mid-career award (K24, NIDDK) in patient oriented pelvic floor research and mentors many young investigators. She has 371 publications, many in top journals such as JAMA and NEJM. Dr. Richter is the ACOG representative to the Section for Enhancing Geriatric Understanding and Expertise among Surgical and Medical Specialists (SEGUE) council of the American Geriatrics Society/Hartford Foundation. She has a strong interest in treating vesicovaginal fistulas and has visited Africa regularly for over 17 years.

Presentation(s):

• Late-Breaking: Preoperative frailty in older women undergoing prolapse surgery: 36 to 60 month outcomes

  Wednesday, October 4, 2023
  5:10 PM – 5:20 PM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• BEST OVERALL PAPER: Characteristics Associated with Surgical Failure after Native Tissue Apical Prolapse Repair

  Wednesday, October 4, 2023
  5:30 PM – 5:40 PM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• General Session IV

  Thursday, October 5, 2023
  8:00 AM – 9:15 AM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Impact of Labor Duration on Pelvic Symptoms in Women Randomized to Immediate Vs Delayed Pushing

  Thursday, October 5, 2023
  11:14 AM – 11:18 AM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Association of Race Status and Pelvic Organ Prolapse Treatment Goal Identification and Assessment with Urogynecology Providers

  Thursday, October 5, 2023
  11:28 AM – 11:32 AM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Posterior Tibial Nerve Stimulation With versus Without Mirabegron in Women with Refractory UUI

  Thursday, October 5, 2023
  3:30 PM – 3:39 PM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Impact of pelvic floor muscle training with and without a motion-based device on pelvic floor disorder symptoms

  Thursday, October 5, 2023
  4:04 PM – 4:08 PM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Digital Therapeutic Device for Urinary Incontinence: An 18- and 24-month Follow-up of a Randomized Controlled Trial

  Thursday, October 5, 2023
  4:08 PM – 4:12 PM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Urethral Anatomy Associated with Prolapse Recurrence and Urinary Symptoms After Uterovaginal Prolapse Repair with Mid-urethral Sling

  Thursday, October 5, 2023
  4:24 PM – 4:28 PM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)

• Importance of Industry Collaboration to Advance Patient Care and Access to Treatment

  Friday, October 6, 2023
  11:00 AM – 11:30 AM US PST

  Disclosure(s): Allergan: Clinical Trial Investigator (Terminated, January 28, 2022); BlueWind Medical: DSMB Member (Ongoing); Coloplast: Consultant/Advisory Board (Ongoing); COSM: Consultant/Advisory Board (Ongoing); EBT Medical: Clinical Trial Investigator (Terminated, December 31, 2022); Laborie: Consultant/Advisory Board (Ongoing); Neomedic: Consultant/Advisory Board (Ongoing); Palette Life Science: Consultant/Advisory Board (Ongoing); Reia LLC: Clinical Trial Investigator (Ongoing); Renovia: Clinical Trial Investigator (Ongoing)